Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

“…<p>Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts.…”

Pre-RT and post RT D-dimer levels in associated with prognostic significance. by Huriye Senay Kiziltan (22298378)

Subjects:

Frontier analysis of injuries’ burden caused by fire, heat, and hot substances from 1990 to 2021. by Shi Huang (125861)

Subjects:

Proportion of the increase (green) or decrease (red) in forest cover in areas with different fire recurrences in Africa, according to the Mann-Kendall test and statistically significance values. by Oswaldo Maillard (20660661)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”

Trends in the burden of stroke attributed to smoking. by Jaber S. Alqahtani (8822396)

Subjects:

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

Subjects:

National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020. by Luke R. Cavanah (19022435)

Subjects:

Projected global leukemia burden, 1990-2050. by Chengjun Hu (588206)

Subjects:

The heatmap of two types high alcohol use-related Stroke showing ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) across 21 GBD regions... by Nannan Qian (10650782)

Subjects:

Health inequality regression curves and concentration curves for the DALYs of two types of high alcohol use-related Stroke worldwide, 1990 and 2021. by Nannan Qian (10650782)

Subjects:

Population-level determinant changes in aging, population growth, and epidemiological changes for two types of high alcohol use-related Stroke DALYs globally and in various SDI reg... by Nannan Qian (10650782)

Subjects:

ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) of high alcohol use-related Stroke in both sexes combined in global in 2021. by Nannan Qian (10650782)

Subjects:

ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) of high alcohol use-related Stroke in both sexes combined in global and five SDI region... by Nannan Qian (10650782)

Subjects:

The EAPC of ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) of high alcohol use-related Stroke in both sexes combined across 21 GBD reg... by Nannan Qian (10650782)

Subjects:

The age-specific burden of high alcohol use-related Stroke, death and ASMR (A), DALYs and ASDR (B), YLDs and Age-Standardized Rate of YLDs (C), YLLs and Age-Standardized Rate of YL... by Nannan Qian (10650782)

Subjects:

ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) for two types of high alcohol use-related Stroke in both sexes combined globally, 1990–... by Nannan Qian (10650782)

Subjects: